Bacteriophage Consortium Selection to Limit Pseudomonas Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling Pseudomonas syringae infections in plants face challenges such as antibiotic resistance, environmental persistence, wide host range, and disease spread, with existing bacteriophage treatments risking resistance development.
Innovation Solution
A method for selecting bacteriophages that exhibit synergistic lytic activity against Pseudomonas syringae without affecting beneficial bacteria, involving geographical sampling, amplification, and double-layer agar techniques to identify strains with cross-synergy, followed by application in crops during high bacterial load periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a single bacteriophage strain is used to control Pseudomonas syringae, then the treatment is simple and cost-effective, but the bacteria can develop resistance quickly
Solution Approach 1:
The patent combines multiple bacteriophage strains into a single treatment composition that targets Pseudomonas syringae. This merging approach maintains ease of application (single composition) while improving reliability through the synergistic effect of multiple phages that can overcome bacterial resistance mechanisms. The composition includes phages with different host ranges and lytic mechanisms, ensuring that if bacteria resist one phage, they remain vulnerable to others in the combination.
2Reliability
If multiple bacteriophage strains are combined to prevent resistance, then the treatment effectiveness increases, but the complexity of selection and formulation increases
Solution Approach 1:
The patent performs preliminary screening and selection of bacteriophage strains before final formulation. This involves pre-characterizing phages for their host range, lytic efficiency, and stability properties, then selecting a complementary set that targets Pseudomonas syringae effectively. This preliminary action reduces the complexity of the final formulation process by ensuring that only pre-validated, compatible phage strains are combined, streamlining the overall development and application process.
3Productivity
If bacteriophages are applied early in the infection cycle, then the treatment is more effective, but the timing must be precisely monitored
Solution Approach 1:
The patent creates a dynamic bacteriophage composition that can adapt to different stages of bacterial infection. The formulation includes phages with varying host ranges and infection mechanisms, allowing the composition to remain effective whether applied preventively or curatively. This dynamic approach reduces the need for precise timing monitoring because the phage mixture can effectively target bacteria at multiple infection stages, providing flexibility in application timing while maintaining high efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The selected bacteriophages achieve a 99% reduction in bacterial population within an hour in vitro and demonstrate a synergistic effect in reducing Pseudomonas syringae infections by up to three orders of magnitude in plant models, maintaining stability for at least 5 months with co-formulant addition.
Implementation Method 1
selected bacteriophages that have lytic and/or enzyme lytic activity against phytopathogens
Implementation Method 2
lytic and/or enzyme lytic activity
Implementation Method 3
Obtain individual lysis plates using the double-layer agar technique
Implementation Method 4
The bacteria then penetrate the leaves to eventually cause the disease
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A method is described for selecting bacteriophages for the biological control of infections in plants, trees, or plant pathogens, which includes several stages. First, a geographical area is identified with nearby water sources close to crops of interest. Then, soil or water samples are collected, and bacteriophages are amplified in two rounds using an appropriate culture medium. Using the double-layer agar technique, bacteriophages with lytic activity against plant pathogens are selected, ensuring no harm to beneficial bacteria. The synergy or cross-resistance between the selected strains is evaluated, and at least 2 or 3 strains showing lytic and/or enzymatic activity are chosen. Additionally, a preventive and curative treatment is outlined, applying the bacteriophages at key phenological stages of the crop. A consortium of bacteriophages with specific identifications obtained through this method is also mentioned.